Best treatments for chronic myelomonocytic leukemia
3 products may treat chronic myelomonocytic leukemia, spanning FDA drug classes such as nucleoside metabolic inhibitor. The current highest-rated option is azacitidine. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 3 drugs we list for chronic myelomonocytic leukemia, none are yet flagged as generics in our price data, spanning classes such as nucleoside metabolic inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for chronic myelomonocytic leukemia — so confirm the right choice with your prescriber.
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Injectable | Nucleoside Metabolic Inhibitor | No data | — | View → | |
| 2 | Not yet rated | Prescription | Tablet | Nucleoside Metabolic Inhibitor | No data | — | View → | |
| 3 | Not yet rated | Prescription | Injectable | Nucleoside Metabolic Inhibitor | No data | — | View → |
Narrow by drug class
Explore the class hubs: nucleoside metabolic inhibitor
Full ranking · 3 treatments
azacitidine
PrescriptionFDA-sourced
Azacitidine is a nucleoside metabolic inhibitor used to treat Refractory Anemia, Sideroblastic Anemia, Chronic Myelomonocytic Leukemia.
Price varies
onureg
PrescriptionFDA-sourced
Onureg (Azacitidine) is a nucleoside metabolic inhibitor used to treat Refractory Anemia, Sideroblastic Anemia, Chronic Myelomonocytic Leukemia.
Price varies
vidaza
PrescriptionFDA-sourced
Vidaza (Azacitidine) is a nucleoside metabolic inhibitor used to treat Refractory Anemia, Sideroblastic Anemia, Chronic Myelomonocytic Leukemia.
Price varies
Frequently asked
- What treats chronic myelomonocytic leukemia?
- Our catalog lists 3 products that may treat chronic myelomonocytic leukemia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is azacitidine.
- What is the best-rated treatment for chronic myelomonocytic leukemia?
- By our independent recall-safety rating — not an efficacy measure — azacitidine ranks highest among the products we list for chronic myelomonocytic leukemia. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat chronic myelomonocytic leukemia?
- Treatments for chronic myelomonocytic leukemia span FDA drug classes including nucleoside metabolic inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.